RecruitingPhase 4NCT07303738

The Use of High Bile-binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations (Aim 1)

The Use of High Bile-Binding Foods to Reduce Upper Gastrointestinal Bile Acid Concentrations: A Novel Intervention for Children at Risk for Aspiration-Associated Complications (Aim 1)


Sponsor

Boston Children's Hospital

Enrollment

60 participants

Start Date

Dec 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

We will perform an acute physiology study comparing three different diets-an amino acid-based formula, a low bile acid-binding blenderized diet, or a high bile acid-binding blenderized diet administered through gastrostomy tube. We will determine the differences in gastric and salivary bile acid concentrations between participants over the 4 hour post-prandial timeframe. Participants who regularly receive an amino acid-based formula will receive an amino acid-based formula during the study and participants who regularly receive a blenderized feed will receive a blenderized feed during the study. Only participants who regularly receive blenderized feeds will be randomized to receive either the high or low bile acid binding blenderized feed.


Eligibility

Min Age: 5 YearsMax Age: 21 Years

Inclusion Criteria3

  • receive at least 80% of their nutritional needs by gastrostomy
  • receive either an amino acid-based formula, an International Dysphagia Diet Standardization Initiative level 4 commercial blend, or a home blend
  • can receive bolus feeds of 240 cc within 30 minutes or less

Exclusion Criteria5

  • have received a fundoplication
  • receive post-pyloric feeds
  • require medication/flush administration during the four-hour study period
  • are allergic to any component of the study diets.
  • To participate in this study, if patients are taking acid suppression or motility medications (e.g., erythromycin, azithromycin, prucalopride), they will need to stop these at least 72 hours prior to participation in this aim.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGamino acid based formula (e.g. Elecare Jr)

We will administer one bolus of an amino acid based formula

DRUGlow bile acid binding blenderized diet (e.g. Kate Farms)

We will administer one bolus of a low bile acid binding blenderized diet

DRUGhigh bile acid binding blenderized diet

We will administer one bolus of a high bile acid binding blenderized diet


Locations(1)

Boston Children's Hospital

Boston, Massachusetts, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07303738


Related Trials